Gilead Completes $7.8 Billion Arcellx Acquisition Deal
Gilead Sciences has finalized its acquisition of Arcellx, completing a deal valued at approximately $7.8 billion.…
Trending
- Gilead Completes $7.8 Billion Arcellx Acquisition Deal
- EU Approves Rhapsido for Chronic Hives Treatment
- Lilly to Acquire Ajax in $2.3 Billion Deal
- Saphnelo Pen Approval Expands Lupus Treatment Access
- BioMarin Completes $4.8 Billion Amicus Acquisition
- Sun Pharma to Acquire Organon in $11.75 Billion Deal
- Leinco, CellCarta Partner to Advance Proteomics in Oncology
- Cipla Wins US Approval for Generic Ventolin Inhaler
- Regeneron Goes All In on Radiopharma with $2.1B Telix Deal as Industry Leaders Convene at TRP Summit
- MSD, Google Cloud Forge $1B AI Partnership
Top Headlines
EU Approves Rhapsido for Chronic Hives Treatment
Novartis has secured approval from the European Commission for its novel therapy Rhapsido, marking a significant…
Lilly to Acquire Ajax in $2.3 Billion Deal
Eli Lilly and Company has announced a definitive agreement to acquire Ajax Therapeutics, a move aimed at…
Saphnelo Pen Approval Expands Lupus Treatment Access
AstraZeneca has received approval from the U.S. Food and Drug Administration for a new self-administered version of…
BioMarin Completes $4.8 Billion Amicus Acquisition
BioMarin Pharmaceutical Inc. has finalized its acquisition of Amicus Therapeutics in an all-cash deal valued at…
Sun Pharma to Acquire Organon in $11.75 Billion Deal
Sun Pharmaceutical Industries Limited has announced a landmark agreement to acquire Organon & Co. in an…
Featured Event
Clinical Trials
Akeso Advances First Trispecific Antibody Into Clinical Trials
Akeso, Inc. has announced that its novel trispecific antibody candidate, AK150, has received Investigational New Drug (IND) clearance from the…
Vima Therapeutics Advances Dystonia Drug Into Phase 2 Trials
Vima Therapeutics has announced significant progress in the development of its experimental treatment for movement disorders, revealing that the first…
Akeso and INOVIO Partner on Novel Glioblastoma Combination Trial
Biotechnology companies Akeso, Inc. and INOVIO have announced a clinical trial collaboration and supply agreement to evaluate a new combination…
Novartis Remibrutinib Shows Phase III Success in CIndU
Novartis has announced positive topline results from its pivotal Phase III RemIND trial evaluating oral remibrutinib in patients with chronic…
Johnson & Johnson Reports Promising OrigAMI-4 Trial Results
Johnson & Johnson has unveiled new data from its Phase 1b/2 OrigAMI-4 study, demonstrating that first-line treatment with investigational…
IQVIA, Boehringer Ingelheim Partner on Global Commercial Data Transformation
IQVIA, a global provider of clinical research services, healthcare intelligence, and commercial insights, has entered into a strategic long-term…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
MSD, Google Cloud Forge $1B AI Partnership
MSD, known as Merck & Co., Inc. in the United States, has entered into a major multi-year partnership with…
Boehringer Expands AI Footprint With London Innovation Hub
Boehringer Ingelheim has announced a major expansion of its global Computational Innovation network with the launch…
Drug Research
UK Streamlines Drug Approvals to Accelerate Patient Access
The Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care…
Novartis Targets Breast Cancer With Novel PI3Kα Inhibitor Deal
Novartis has announced a strategic agreement with Synnovation Therapeutics, LLC to acquire SNV4818, an…
FDA Proposes New Steps to Streamline Biosimilar Drug Development
The U.S. Food and Drug Administration has announced a new regulatory initiative aimed at accelerating the…
Insilico, CMS Partner on AI Drug Discovery Programs
Clinical-stage biotechnology company Insilico Medicine and pharmaceutical commercialization group China Medical…
China Approves ENHERTU for Second-Line HER2-Positive Gastric Cancer
China’s National Medical Products Administration (NMPA) has approved ENHERTU® (trastuzumab deruxtecan) for the…
Manufacturing
Piramal, Ajinomoto Partner to Advance ADC Manufacturing Capabilities
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration aimed at…
UCB Selects Georgia for Major U.S. Biologics Manufacturing Hub
UCB has announced plans to establish a major new biologics manufacturing facility in Gwinnett County, Georgia,…
LGM Pharma Expands U.S. Manufacturing With $15M Investment
LGM Pharma has announced a $9 million expansion across its U.S. manufacturing network, marking the second phase of…
Terumo BCT, Taiwan Bio Partner on Treg Manufacturing
Terumo Blood and Cell Technologies (Terumo BCT) has entered into a strategic collaboration with Taiwan Bio…
CordenPharma Leases New Lab Facility at Boulder’s Flatiron Park
BioMed Realty has announced that CordenPharma Colorado has signed a long-term lease for a new laboratory facility…
Novo Nordisk Invests €432M to Expand Irish GLP-1 Manufacturing
Pharmaceutical giant Novo Nordisk has announced a €432 million investment to expand its manufacturing facility in…
AbbVie Invests $380M in North Chicago Manufacturing
AbbVie has unveiled plans to invest $380 million to construct two new active pharmaceutical ingredient (API)…
Johnson & Johnson Invests $1 Billion in Pennsylvania
Johnson & Johnson has announced plans to invest more than $1 billion in a next-generation cell therapy…
Diseases
Tenaya and Alnylam Partner to Discover New Genetic Targets for Heart Disease
Clinical-stage biotechnology company Tenaya Therapeutics has announced a new research collaboration with RNA…
AstraZeneca, CSPC Partner on Next-Generation Obesity Therapies
AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic…
China Approves ENHERTU for Second-Line HER2-Positive Gastric Cancer
China’s National Medical Products Administration (NMPA) has approved ENHERTU® (trastuzumab deruxtecan) for the…
InterAx, Alveus Partner to Advance Next-Generation Obesity Therapy
InterAx Biotech Ltd and Alveus Therapeutics Inc. have entered into a strategic research collaboration and licensing…
Sandoz to Acquire Just-Evotec Biologics Facility in Toulouse Under New Term Sheet
Sandoz has signed a non-binding term sheet with Evotec SE to potentially acquire Just–Evotec Biologics EU SAS,…
AstraZeneca and Revna Biosciences Expand Lung Cancer Treatment Access in Ghana
Since announcing their partnership in April 2025, AstraZeneca and Revna Biosciences have made significant strides…
